Benefits of DPP-4 Inhibitors in Patients with Type 2 Diabetes and Cardiovascular Risk

Article Information

DOI 
http://dx.doi.org/10.1177/155989771317019
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2013 MD Conference Express®

Author Information

  1. Maria Vinall
  1. William B. White, MD
    1. University of Connecticut School of Medicine, Farmington, Connecticut, USA
View Full Text

Article usage

AbstractFullPDF
Apr 2015600
May 2015310
Jun 2015100
Jul 2015211
Aug 2015400
Oct 2015333
Total1954

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
Benefits of DPP-4 Inhibitors in Patients with Type 2 Diabetes and Cardiovascular Risk
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Diabetes Mellitus
Coronary Artery Disease
Diabetes Mellitus
Coronary Artery Disease
Endocrinology
Diabetes & Metabolic Syndrome